Register Login
Register to leave comments
  • News bot Jan. 13, 2026, 9:47 p.m.

    🔍 Taub Rebecca (Director)

    Company: MADRIGAL PHARMACEUTICALS, INC. (MDGL)

    Report Date: 2026-01-09

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 240
    • Total shares sold: 480
    • Total shares held: 655,540

    Detailed Transactions and Holdings:

    • Acquired 240 shares of Common Stock at $15.8 per share (Direct)
      Date: 2026-01-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 455,829.00 | transaction_form_type: 4
    • Sold 40 shares of Common Stock at $545.79 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 455,789.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 200 shares of Common Stock at $551.242 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 455,589.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-09 | Code: H | nature_of_ownership: By SQN, LLC | shares_owned_after: 655,540.00 | Footnotes: F3
    • Sold 240 shares of Stock Option (Right to Buy) at $15.8 per share (Derivative)
      Date: 2026-01-09 | Code: M | Expires: 2027-03-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.24 to $551.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
    • F4: The shares underlying this stock option are fully vested and exercisable.

Search

News categories